2-Chloro-4-methyl-6-nitroquinoline
CAS: 54965-59-2
Rif. 3D-FC128896
1g | Fuori produzione | ||
2g | Fuori produzione | ||
5g | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- quinoline
- 2-chloro-4-methyl-6-nitro-
- Quinoline, 2-chloro-4-methyl-6-nitro-
2-Chloro-4-methyl-6-nitroquinoline is a promyelocytic leukemia (PML) treatment drug that is used to inhibit the growth of leukemia cells. It has been shown to be effective in inducing the death of leukemia cells in vitro and in vivo. This activity is due to its ability to bind and inhibit topoisomerase II, which prevents the unwinding of DNA strands during replication. 2-Chloro-4-methyl-6-nitroquinoline also inhibits multidrug resistance, which may be due to its ability to induce cytotoxicity.
The following product descriptions are generated from the information given above:
Rifapentine is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA dependent RNA polymerase